The phrase 'substitutable for' is correct and usable in written English.
It is used to describe something that can be replaced or interchanged with something else. For example, "This machine is substitutable for the one that broke down."
Such substitution costs may arise due to a variety of reasons: the cost of the reworking required on an item to make it substitutable for the other, loss of a customer's goodwill due to substitution, etc. Deterioration of physical goods in stock is a very realistic feature and there is a big need to consider it in the inventory modelling of substitutable items.
E.g., φ → Universal Instantiation: ∀αφ → φ, where φ is the result of uniformly substituting τ for the free occurrences of α in φ and τ is substitutable for α (i.e., no variable free in τ becomes bound by any quantifier in φ.
And because such products are normally substitutable for one another, something like a standard price emerges.
The two chains provide competitive products, either identical or highly substitutable, for some participating retailer markets.
The empirical evidence does not suggest that labor and capital are sufficiently substitutable for this to occur.
But the result of this is that workers become more readily substitutable for one another, which reduces their value to the firm.
Over the nexus with minerals such as phosphorus being non-substitutable for world food production [11], or the vast array of resources needed for urbanization and.
In this sequence, Drezner et al. (1995) developed an EOQ model with substitution for two substitutable products and compare the results with no substitution.
In intermediate cases, i.e. when the firms produce complementary services for some customers and substitutable services for others, the regulators' view regarding collusion should depend on the weight they put on welfare provided for the different groups of customers.
The process of simultaneous utilization of two substitutable substrates for growth purposes in a continuously operated cyclic bioreactor was described with a mathematical model.
Seretide – which is likely to avoid direct substitutable competition for most of this period despite loss of patent exclusivity – is forecast to deliver cumulative sales of $32.2 billion.
